[Autophagy of prostate cancer PC-3 cells under the induction of oridonin]

Li-hong Ye1, Yong-liang Chen, Shui-xiang Tao

  • 1Shaoxin Central Hospital, Shaoxin 312030, China. LLH7966@126.com

Zhonghua Yi Xue Za Zhi
|January 8, 2011
PubMed
Abstract

Insights

Oridonin (ORI) inhibits prostate cancer PC-3 cell growth by inducing autophagy. This natural compound triggers cellular self-degradation pathways, showing potential as an anti-tumor agent.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Pharmacology

Context:

  • Prostate cancer remains a significant health concern, necessitating novel therapeutic strategies.
  • Oridonin, a compound derived from Rabdosia rubescens, has demonstrated cytotoxic effects in various cancer cell lines.
  • Understanding the precise mechanisms underlying oridonin's anti-cancer activity is crucial for its clinical development.

Purpose:

  • To elucidate the mechanism by which oridonin (ORI) induces autophagy in prostate cancer PC-3 cells.
  • To investigate the morphological and molecular changes associated with oridonin treatment in PC-3 cells.
  • To assess the role of autophagy in oridonin-mediated anti-cancer effects.

Summary:

  • Oridonin treatment significantly inhibited PC-3 cell proliferation in a dose- and time-dependent manner.
  • Morphological analysis revealed cellular shrinkage and the formation of autophagosomes, indicative of autophagy.
  • Oridonin upregulated the expression of autophagy-related proteins (MAP1-LC3) and mRNA (beclin 1), which was reversed by the autophagy inhibitor 3-MA.

Impact:

  • This study reveals that oridonin induces autophagy in prostate cancer cells, contributing to its anti-tumor effects.
  • The findings suggest that oridonin holds potential as a therapeutic agent for prostate cancer.
  • Further research into oridonin's anti-cancer mechanisms could pave the way for novel treatment strategies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...